Request Information
Right Price, The: A Value-Based Prescription for Drug Costs
- Publication Year:
- 2021
- Edition:
- 1st
- Author:
- Neumann, Peter
- Publisher:
- Oxford University Press
- ISBN:
- 978-0-19-751288-3
-
Description
-
Details
-
Collections
-
Also Recommended
Description
Sheds light on the controversial topic of drug pricing by providing an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies.
The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the other hand, healthy industry returns have arguably fueled life-saving innovation. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million-dollar price tags, the need for sensible drug pricing policies will only intensify.
The Right Price illustrates the need for value-based pricing through real-life stories of patients and their experiences with the drug industry and explains why simple solutions like price controls and the importation of cheaper drugs from other countries are problematic. This volume describes how researchers and policy makers have pursued drug valuation efforts in the past, and lays out a series of recommendations, based on years of shared author experience serving on national drug policy platforms, for how to further improve pharmaceutical value assessment in the United States.
With unique industry insights and clear narrative, The Right Price unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.
The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the other hand, healthy industry returns have arguably fueled life-saving innovation. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million-dollar price tags, the need for sensible drug pricing policies will only intensify.
The Right Price illustrates the need for value-based pricing through real-life stories of patients and their experiences with the drug industry and explains why simple solutions like price controls and the importation of cheaper drugs from other countries are problematic. This volume describes how researchers and policy makers have pursued drug valuation efforts in the past, and lays out a series of recommendations, based on years of shared author experience serving on national drug policy platforms, for how to further improve pharmaceutical value assessment in the United States.
With unique industry insights and clear narrative, The Right Price unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.
Details
- Platform:
- OvidSP
- Publisher:
- Oxford University Press
- Product Type:
- Book
- Author:
- Neumann, Peter
- ISBN:
- 978-0-19-751288-3
- Specialty:
-
- Health Policy
- Pharmacology
- Language:
- English
- Edition:
- 1st
- Pages:
- 274
- Publication Year:
- 2021
- Advanced Practice Nursing Leadership: A Global Perspective
- Anti-Microbial Resistance in Global Perspective
- Autobiography of a Persistent Anesthesiologist
- Care Coordination and Transition Management Core Curriculum
- Case Management: A Practical Guide for Education and Practice
- Clinical Handbook of Psychiatry and the Law
- Clinical Prediction Models
- Contemporary Biostatistics with Biopharmaceutical Applications
- Coping with COVID 19: The Medical, Mental, and Social Consequences of the Pandemic
- Defining Excellence in Simulation Programs
- Diversity Promise, The: Success in Academic Surgery and Medicine Through Diversity, Equity, and Inclusion
- Ethics of Innovation in Neurosurgery
- Field Guide to the Business of Medicine: Resource for Health Care Professionals
- Guidance for Healthcare Ethics Committees
- Handbook for Culturally Competent Care
- Heart Teams for Treatment of Cardiovascular Disease: A Guide for Advancing Patient-Centered Cardiac Care
- Journey towards Patient-Centered Healthcare Quality, A
- Leadership in Nursing: Experiences from the European Nordic Countries
- Legal Concepts and Best Practices in Obstetrics: The Nuts and Bolts Guide to Mitigating Risk
- Oxford Handbook of Public Health Practice
- Personalized Medicine in Healthcare Systems
- Population Change and Public Policy
- Power and Risk in Policymaking
- Quality of Life and Person-Centered Care for Older People
- Refugee Health Care
- Stepped Care 2.0: A Paradigm Shift in Mental Health
- Suicide and Suicide Prevention From a Global Perspective
- Transforming the Heart of Practice: An Organizational and Personal Approach to Physician Wellbeing
- Urban Public Health: A Research Toolkit for Practice and Impact